Abstract

PL02 Presentation Time: 1:45 PM: HDR Monotherapy for Low and Intermediate Risk Prostate Cancer: Update of a Randomized Trial

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call